| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.004 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.33 | 0.004 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.005 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.099 | 0.008 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.009 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |